Related to Roche Allies with MGH and Harvard to Develop Stem Cell-Derived Cell Lines for Drug Discovery

• Three Often-Used Esophageal Cancer Cell Lines Found to Be from Other Cancers
  
• Roche to Plug Over $181M Into Manufacturing Sites to Produce Self-Administration Device for Herceptin
  
• EC Sanctions Roche’s Herceptin for HER2-Positive Metastatic Gastric Cancer
  
• Roche Makes Near $95M Investment in Singapore-Based Center for Translational Medicine
  
• TGen Gains Open Access to Horizon’s Gene-Engineering and Isogenic Cancer Cell Line Platform
  
• International Stem Cell Opens Production Site for Clinical-Grade Stem Cell Products
  
• Roche Reports Positive Data from Five Phase III Trials of Type 2 Diabetes Therapy
  
• ReNeuron Raises £4.7M to Fund Phase I Study with Stem Cell Therapy for Ischemic Stroke
  
• Roche’s Avastin Fails to Improve Survival of Advanced Stomach Cancer Patients in Phase III Trial
  
• Phase III Trial Suggests Avastin Maintenance Therapy Increases PFS in Advanced Ovarian Cancer
  
• Roche and Biogen Idec Put the Brakes on Development of Ocrelizumab in RA
  
• Roche’s Avastin Fails in Late-Stage Hormone-Refractory Prostate Cancer Study
  
• Horizon Acquires Human Isogenic Cell Models of DNA Damage Repair from University of Minnesota
  
• TAP Negotiates Additional Distribution Rights to Aviso’s Automated Stem Cell Picker
  
• Newly Established Firm Aims to Speed Development of Stable Cell Lines and Primary Cells for R&D
  
• EU Approves Roche’s Xeloda Combined with Oxaliplatin for Post-Surgical Colon Cancer Therapy
  
• Veritas to Supply International Stem Cell’s Products in Japan
  
• Fate Therapeutics Takes Over Verio to Pad Stem Cell Modulator Pipeline
  
• Stemgent to Supply Stem Cell Related Reagents from Pfizer
  
• FDA Okays Tarceva as Maintenance Therapy of NSCLC after Chemotherapy